Raxar
The antibiotic Raxar was approved in November 1997 despite evidence from clinical studies suggesting it could cause several fatal heart-rhythm disruptions. Click on FAQ on Arrhythmia: Raxar, to learn more about this issue.
When Raxar clinical trials came under review by the FDA, a medical officer suspected that two out of four patients who died after taking Raxar in clinical trials possibly suffered heart-rhythm disturbances caused by the drug. FDA officials, however, chose...MORE >>
Featured Articles on Raxar
Browse Books About Drug Litigation
The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation.